Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Skin Neoplasms
×
Vemurafenib
×
Clear all
Filters
3
NCT01909453
2026-02-27
COLUMBUS
Pfizer
Phase 3
Completed
921 enrolled
48 charts
1 FDA
NCT01683188
2021-02-01
PROCLIVITY01
Clinigen, Inc.
Phase 4
Terminated
53 enrolled